# Noom's GLP-1Rx Program Combines Medication with Behavioral Support for Weight Loss
Noom Med has launched a GLP-1Rx program that pairs prescription weight loss medications with the company's behavioral coaching platform. The approach addresses a gap in how GLP-1 receptor agonists are typically prescribed, which often involves medication alone without structured lifestyle guidance.
GLP-1 drugs like semaglutide and tirzepatide have transformed weight loss treatment by reducing appetite and improving blood sugar control. However, prescribing these medications without behavioral support can limit their effectiveness. Noom's program integrates medication management with daily coaching, habit tracking, and personalized nutrition guidance designed to maximize results.
The program works through telemedicine consultations where clinicians assess whether GLP-1 therapy is appropriate for individual patients. Once prescribed, users access Noom's established behavioral platform, which uses psychology-based principles to help people understand their eating patterns and build sustainable habits. The company positions this combination as more comprehensive than medication-only approaches.
Noom's model reflects growing evidence that weight loss medications work best when combined with lifestyle interventions. Research published in obesity medicine journals consistently shows that behavioral support improves medication adherence and long-term outcomes. Patients who understand why they eat certain foods and develop alternative coping strategies tend to maintain weight loss better than those taking medication alone.
The program also addresses cost barriers that prevent many people from accessing both medications and coaching simultaneously. By bundling these services, Noom offers an integrated option that some insurers may cover more readily than separate medical and coaching services.
The GLP-1Rx program represents a shift toward multidisciplinary weight loss treatment in digital health. Rather than viewing medication and behavior change as separate interventions, Noom treats them as complementary components of one system. This approach aligns with clinical